01.08.2002 | Original Article
Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer
Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 2/2002
Einloggen, um Zugang zu erhalten